Guizhou Xinbang Pharmaceutical Co Ltd
Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological m… Read more
Guizhou Xinbang Pharmaceutical Co Ltd - Asset Resilience Ratio
Guizhou Xinbang Pharmaceutical Co Ltd (002390) has an Asset Resilience Ratio of 0.01% as of September 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2017)
This chart shows how Guizhou Xinbang Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Guizhou Xinbang Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.00 Million | 0.01% |
| Total Liquid Assets | CN¥1.00 Million | 0.01% |
Asset Resilience Insights
- Limited Liquidity: Guizhou Xinbang Pharmaceutical Co Ltd maintains only 0.01% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Guizhou Xinbang Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Guizhou Xinbang Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma
KO:000220 |
Drug Manufacturers - Specialty & Generic | 1.74% |
|
Ildong Holdings Co Ltd
KO:000230 |
Drug Manufacturers - Specialty & Generic | 1.57% |
Annual Asset Resilience Ratio for Guizhou Xinbang Pharmaceutical Co Ltd (2012–2017)
The table below shows the annual Asset Resilience Ratio data for Guizhou Xinbang Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 0.67% | CN¥80.00 Million | CN¥11.95 Billion | -0.63pp |
| 2016-12-31 | 1.30% | CN¥140.00 Million | CN¥10.80 Billion | +0.53pp |
| 2015-12-31 | 0.77% | CN¥50.00 Million | CN¥6.50 Billion | +0.86pp |
| 2014-12-31 | -0.10% | CN¥-4.99 Million | CN¥5.22 Billion | -5.48pp |
| 2013-12-31 | 5.38% | CN¥80.00 Million | CN¥1.49 Billion | +3.88pp |
| 2012-12-31 | 1.50% | CN¥20.00 Million | CN¥1.33 Billion | -- |